Fingerprint
Dive into the research topics where David Luis Ramirez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial
Reddy, J. P., Sherry, A. D., Fellman, B., Liu, S., Bathala, T., Haymaker, C., Cohen, L., Smith, B. D., Ramirez, D., Shaitelman, S. F., Chun, S. G., Medina-Rosales, M., Teshome, M., Brewster, A., Barcenas, C. H., Reuben, A., Ghia, A. J., Ludmir, E. B., Weed, D. & Shah, S. J. & 4 others, , Mar 15 2025, In: International Journal of Radiation Oncology Biology Physics. 121, 4, p. 885-893 9 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer
Raghavendra, A. S., Kettner, N. M., Kwiatkowski, D., Damodaran, S., Wang, Y., Ramirez, D., Gombos, D. S., Hunt, K. K., Shen, Y., Keyomarsi, K. & Tripathy, D., Dec 2025, In: npj Breast Cancer. 11, 1, 7.Research output: Contribution to journal › Article › peer-review
Open Access11 Link opens in a new tab Scopus citations -
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy
Iwase, T., Cohen, E. N., Gao, H., Alexander, A., Kai, M., Chiv, V., Wang, X., Krishnamurthy, S., Liu, D., Shen, Y., Kida, K., Reuben, A., Layman, R. M., Ramirez, D. L., Tripathy, D., Moulder, S. L., Yam, C., Valero, V., Lim, B. & Reuben, J. M. & 1 others, , Jun 1 2024, In: Clinical Cancer Research. 30, 11, p. 2424-2432 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study
Yam, C., Patel, M., Hill, H. A., Sun, R., Bassett, R. L., Kong, E., Damodaran, S., Koenig, K. B., Abouharb, S., Saleem, S., Bisen, A. K., Murthy, R. K., Ramirez, D. L., Rauch, G. M., Adrada, B. E., Candelaria, R. P., Wang, X., Mittendorf, E. A., Thompson, A. M. & White, J. B. & 19 others, , Oct 2024, In: Cancer Research Communications. 4, 10, p. 2823-2834 12 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
Yam, C., Mittendorf, E. A., Garber, H. R., Sun, R., Damodaran, S., Murthy, R. K., Ramirez, D., Karuturi, M., Layman, R. M., Ibrahim, N., Rauch, G. M., Adrada, B. E., Candelaria, R. P., White, J. B., Ravenberg, E., Clayborn, A., Ding, Q. Q., Symmans, W. F., Prabhakaran, S. & Thompson, A. M. & 5 others, , Jun 2023, In: Breast Cancer Research and Treatment. 199, 3, p. 457-469 13 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Link opens in a new tab Scopus citations